Survivors of breast cancer are at significantly higher risk of developing second cancers, including endometrial and ovarian cancer for women and prostate cancer for men, according to new research studying data from almost 600,000 patients in England.
Tyra gains orphan drug status from FDA for achondroplasia therapy
Mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene have been linked to achondroplasia or dwarfism. Credit: LANL (Los Alamos National Lab) /
August 2, 2023